Literature DB >> 17393947

Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma.

Orcun Ciftci1, Ahmet Mesut Onat, Bunyamin Yavuz, Ali Akdogan, Kudret Aytemir, Lale Tokgozoglu, Levent Sahiner, Ali Deniz, Kemal Ureten, Guler Kizilca, Meral Calguneri, Ali Oto.   

Abstract

BACKGROUND: Cardiac involvement in scleroderma is a poor prognostic sign and is usually underdiagnosed, particularly in asymptomatic patient. This paper focuses on QT dynamicity and heart rate variability (HRV) in patients with scleroderma and controls in an attempt to investigate the cardiac autonomic system and ventricular repolarization.
METHODS: Sixty patients with scleroderma and 30 age- and sex-matched healthy controls who had no cardiovascular risk factors were included in this study. All patients and the controls underwent a 24-hour holter recording as well as a transthoracic echocardiography. HRV and QT dynamicity parameters were calculated.
RESULTS: In HRV analysis, autonomic balance was changed in favor of the sympathetic system in patients with diffuse scleroderma. In QT dynamicity analysis, QT/RR slopes were significantly steeper in patients with diffuse scleroderma compared to patients with limited scleroderma and controls (QTapex/RR: 0.24 +/- 0.16, 0.15 +/- 0.03, 0.14 +/- 0.03 respectively p < 0.001; QTend/RR: 0.26 +/- 0.17, 0.14 +/- 0.04, 0.13 +/- 0.05, respectively p < 0.001).
CONCLUSIONS: Patients with diffuse scleroderma may have asymptomatic cardiac repolarization abnormalities and autonomic dysfunction. Our results may indicate that QT dynamicity and HRV can be useful noninvasive methods that may detect impaired state of autonomic balance and cardiac repolarization in patients with diffuse scleroderma.

Entities:  

Mesh:

Year:  2007        PMID: 17393947      PMCID: PMC2569635     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  24 in total

1.  Twenty-four hour heart period variability in systemic sclerosis.

Authors:  S Morelli; G Piccirillo; F Fimognari; A Sgreccia; L Ferrante; G Morabito; P De Marzio; G Valesini; V Marigliano
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

Review 2.  Scleroderma and related conditions.

Authors:  H Mitchell; M B Bolster; E C LeRoy
Journal:  Med Clin North Am       Date:  1997-01       Impact factor: 5.456

3.  QT interval and QT dispersion in systemic sclerosis (scleroderma).

Authors:  A Sgreccia; S Morelli; L Ferrante; C Perrone; P De Marzio; G De Vincentiis; F Scopinaro
Journal:  J Intern Med       Date:  1998-02       Impact factor: 8.989

4.  Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias.

Authors:  R Tavernier; L Jordaens; F Haerynck; E Derycke; D L Clement
Journal:  Eur Heart J       Date:  1997-06       Impact factor: 29.983

5.  Autonomic dysfunction in diffuse scleroderma vs CREST: an assessment by computerized heart rate variability.

Authors:  A G Hermosillo; R Ortiz; J Dábague; J M Casanova; M Martínez-Lavín
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666

6.  Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis.

Authors:  C Ferri; M Emdin; D Giuggioli; C Carpeggiani; M Maielli; A Varga; C Michelassi; G Pasero; A L'Abbate
Journal:  Br J Rheumatol       Date:  1997-06

7.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

Authors:  W P Follansbee; T R Miller; E I Curtiss; J E Orie; R L Bernstein; J M Kiernan; T A Medsger
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

8.  Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report.

Authors:  P J Schwartz; E H Locati; A J Moss; R S Crampton; R Trazzi; U Ruberti
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

9.  Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability.

Authors:  P H Dessein; B I Joffe; R M Metz; D L Millar; M Lawson; A E Stanwix
Journal:  Am J Med       Date:  1992-08       Impact factor: 4.965

10.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Authors:  P Clements; P Lachenbruch; J Siebold; B White; S Weiner; R Martin; A Weinstein; M Weisman; M Mayes; D Collier
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  9 in total

1.  Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case.

Authors:  Fabio Marsico; Gianluigi Savarese; Celestino Sardu; Cristoforo D'Ascia; Donatella Ruggiero; Laura Casaretti; Valentina Parisi; Francesca Musella; Elisabetta Pirozzi; Roberto Formisano; Teresa Losco; Pasquale Perrone Filardi
Journal:  J Cardiol Cases       Date:  2012-03-31

2.  Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.

Authors:  T A McNearney; H S Sallam; S E Hunnicutt; D Doshi; D E Wollaston; M D Mayes; J D Z Chen
Journal:  Neurogastroenterol Motil       Date:  2009-06-30       Impact factor: 3.598

3.  QT variability index in patients with systemic sclerosis.

Authors:  Udi Nussinovitch; Shiri Rubin; Yair Levy; Merav Lidar; Avi Livneh
Journal:  Eur J Rheumatol       Date:  2018-10-01

4.  Assessment of cardiac autonomic nervous system involvement in systemic sclerosis via exercise heart rate recovery.

Authors:  Ugur Nadir Karakulak; Sercan Okutucu; Levent Şahiner; Naresh Maharjan; Elifcan Aladag; Ali Akdogan; Levent Kilic; Ergun Baris Kaya; Kudret Aytemir; Lale Tokgozoglu
Journal:  Med Princ Pract       Date:  2014-11-22       Impact factor: 1.927

5.  Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis.

Authors:  Adam R Poliwczak; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Katarzyna Dworniak-Pryca
Journal:  Postepy Dermatol Alergol       Date:  2019-02-26       Impact factor: 1.837

Review 6.  The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases.

Authors:  Chiara Bellocchi; Angelica Carandina; Beatrice Montinaro; Elena Targetti; Ludovico Furlan; Gabriel Dias Rodrigues; Eleonora Tobaldini; Nicola Montano
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

7.  The Relationship Between Autonomic Dysfunction of the Gastrointestinal Tract and Emotional Distress in Patients With Systemic Sclerosis.

Authors:  Dana DiRenzo; James Russell; Clifton O Bingham; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2021-01-01       Impact factor: 3.902

8.  Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Veronika Sebestyén; Gabriella Szűcs; Dénes Páll; Dóra Ujvárosy; Tamás Ötvös; Imre Csige; Tamás Pataki; István Lőrincz; Zoltán Szabó
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

Review 9.  Sclerodermic Cardiomyopathy-A State-of-the-Art Review.

Authors:  Adrian Giucă; Tea Gegenava; Carmen Marina Mihai; Ciprian Jurcuţ; Adrian Săftoiu; Diana Monica Gȋrniţă; Bogdan Alexandru Popescu; Nina Ajmone Marsan; Ruxandra Jurcuț
Journal:  Diagnostics (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.